{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:50:39Z","timestamp":1793915439568,"version":"4.8.0"},"reference-count":139,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Bazhen Decoction (BZD) is a common adjuvant therapy drug for colorectal cancer (CRC), although its anti-tumor mechanism is unknown. This study aims to explore the core components, key targets, and potential mechanisms of BZD treatment for CRC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Traditional Chinese Medicine Systems Pharmacology (TCMSP) was employed to acquire the BZD\u2019s active ingredient and targets. Meanwhile, the Drugbank, Therapeutic Target Database (TTD), DisGeNET, and GeneCards databases were used to retrieve pertinent targets for CRC. The Venn plot was used to obtain intersection targets. Cytoscape software was used to construct an \u201cherb-ingredient-target\u201d network and identify core targets. GO and KEGG pathway enrichment analyses were conducted using R language software. Molecular docking of key ingredients and core targets of drugs was accomplished using PyMol and Autodock Vina software. Cell and animal research confirmed Bazhen Decoction efficacy and mechanism in treating colorectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      BZD comprises 173 effective active ingredients. Using four databases, 761 targets related to CRC were identified. The intersection of BZD and CRC yielded 98 targets, which were utilized to construct the \u201cherb-ingredient-target\u201d network. The four key effector components with the most targets were quercetin, kaempferol, licochalcone A, and naringenin. Protein-protein interaction (PPI) analysis revealed that the core targets of BZD in treating CRC were AKT1, MYC, CASP3, ESR1, EGFR, HIF-1A, VEGFR, JUN, INS, and STAT3. The findings from molecular docking suggest that the core ingredient exhibits favorable binding potential with the core target. Furthermore, the GO and KEGG enrichment analysis demonstrates that BZD can modulate multiple signaling pathways related to CRC, like the T cell receptor, PI3K-Akt, apoptosis, P53, and VEGF signaling pathway.\n                      <jats:italic>In vitro<\/jats:italic>\n                      , studies have shown that BZD dose-dependently inhibits colon cancer cell growth and invasion and promotes apoptosis. Animal experiments have shown that BZD treatment can reverse abnormal expression of PI3K, AKT, MYC, EGFR, HIF-1A, VEGFR, JUN, STAT3, CASP3, and TP53 genes. BZD also increases the ratio of CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells to CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells in the spleen and tumor tissues, boosting IFN-\u03b3 expression, essential for anti-tumor immunity. Furthermore, BZD has the potential to downregulate the PD-1 expression on T cell surfaces, indicating its ability to effectively restore T cell function by inhibiting immune checkpoints. The results of HE staining suggest that BZD exhibits favorable safety profiles.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>BZD treats CRC through multiple components, targets, and metabolic pathways. BZD can reverse the abnormal expression of genes such as PI3K, AKT, MYC, EGFR, HIF-1A, VEGFR, JUN, STAT3, CASP3, and TP53, and suppresses the progression of colorectal cancer by regulating signaling pathways such as PI3K-AKT, P53, and VEGF. Furthermore, BZD can increase the number of T cells and promote T cell activation in tumor-bearing mice, enhancing the immune function against colorectal cancer. Among them, quercetin, kaempferol, licochalcone A, naringenin, and formaronetin are more highly predictive components related to the T cell activation in colorectal cancer mice. This study is of great significance for the development of novel anti-cancer drugs. It highlights the importance of network pharmacology-based approaches in studying complex traditional Chinese medicine formulations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2023.1235575","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T01:58:20Z","timestamp":1695952700000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":66,"title":["Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation"],"prefix":"10.3389","volume":"14","author":[{"given":"Shuai","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xibo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huazhen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiu","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoya","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenpeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benqiang","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","article-title":"Colorectal cancer","volume":"1","author":"Kuipers","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10759","article-title":"Progress and future direction in the management of advanced colorectal cancer","volume":"105","author":"Brown","year":"2018","journal-title":"Br J Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ags3.12061","article-title":"Recent updates in the surgical treatment of colorectal cancer","volume":"2","author":"Matsuda","year":"2018","journal-title":"Ann Gastroenterol Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci Trans Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ccell.2016.03.005","article-title":"Tumoral immune cell exploitation in colorectal cancer metastases can Be targeted effectively by anti-CCR5 therapy in cancer patients","volume":"29","author":"Halama","year":"2016","journal-title":"Cancer Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.01.069","article-title":"Advances in CRC prevention: screening and surveillance","volume":"154","author":"Dekker","year":"2018","journal-title":"Gastroenterology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky987","article-title":"Etcm: An encyclopaedia of traditional Chinese medicine","volume":"47","author":"Xu","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13046-021-01968-w","article-title":"Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets","volume":"40","author":"Luo","year":"2021","journal-title":"J Exp Clin Cancer research: CR"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.joim.2020.07.005","article-title":"Chinese herbal medicines for prevention and treatment of colorectal cancer: From molecular mechanisms to potential clinical applications","volume":"18","author":"Kong","year":"2020","journal-title":"J Integr Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7193832","article-title":"An analysis of the antineuropathic effects of qi she pill based on network pharmacology","volume":"2020","author":"Song","year":"2020","journal-title":"Evidence-Based Complement Altern Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/biom9100591","article-title":"Investigating the multi-target pharmacological mechanism of Hedyotis diffusa willd acting on prostate cancer: a network pharmacology approach","volume":"9","author":"Song","year":"2019","journal-title":"Biomolecules"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9768414","article-title":"Integrated analysis of the mechanisms of da-chai-hu decoction in type 2 diabetes mellitus by a network pharmacology approach","volume":"2020","author":"Ren","year":"2020","journal-title":"Evidence-Based Complement Altern Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4637839","article-title":"Mechanisms of compound kushen injection for the treatment of lung cancer based on network pharmacology","volume":"2019","author":"Meng","year":"2019","journal-title":"Evidence-Based Complement Altern Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr Comput Aided Drug Des"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01185","article-title":"Integrating network pharmacology and pharmacological evaluation for deciphering the action mechanism of herbal formula zuojin pill in suppressing hepatocellular carcinoma","volume":"10","author":"Guo","year":"2019","journal-title":"Front Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S319786","article-title":"Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of huai hua san against ulcerative colitis","volume":"15","author":"Liu","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/1534735406298991","article-title":"Integrating Chinese and conventional medicine in colorectal cancer 13 treatment","volume":"6","author":"Lahans","year":"2007","journal-title":"Integr Cancer Therapies"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.19347\/j.cnki.2096-1413.20221203","article-title":"Clinical efficacy of Bazhen Tang combined with radiotherapy and chemotherapy in the treatment of cervical cancer and its impact on patient immune function, cancer-related fatigue, and toxic side effects","volume":"7","author":"Cao","year":"2022","journal-title":"Clin Med Res Pract"},{"key":"B20","article-title":"The effect of modified Bazhen Tang combined with moxibustion on tolerance, analgesic effect, and quality of life in patients with advanced cervical cancer undergoing radiotherapy and chemotherapy","volume":"24","author":"Yang","year":"2018","journal-title":"Chin J Exp Prescript"},{"key":"B21","first-page":"240","article-title":"Comparison of the effect of sijunzi decoction, siwu decoction and bazhen decoction on immune function in mice","volume":"18","author":"Xu","year":"1993","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J Chin mater Med"},{"key":"B22","article-title":"In vitro study for detecting the effects of Bazhen decoction on proliferation and activation of T lymphocytes","volume":"27","author":"Liu","year":"2010","journal-title":"Sheng wu yi xue gong cheng xue za zhi = J Biomed Eng = Shengwu yixue gongchengxue zazhi"},{"key":"B23","article-title":"Effects of modified bazhen decoction in assistant with enteral nutrition on the growth hormone, the nutritional state, and the immune function in patients with gastric cancer after operation","volume":"31","author":"Wang","year":"2011","journal-title":"Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chin J integrated traditional Western Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3826080","DOI":"10.1155\/2022\/3826080","article-title":"Study on huangqi bazhen decoction on relieving chemotherapy intestinal mucositis in capecitabine gavage mice","volume":"2022","author":"Shi","year":"2022","journal-title":"Contrast media Mol Imaging"},{"key":"B25","article-title":"Effects and mechanisms of Bazhen decoction, Siwu decoction, and Sijunzi decoction on 5-fluorouracil-induced anemia in mice","volume":"36","author":"Tian","year":"2016","journal-title":"J traditional Chin Med = Chung i tsa chih ying wen pan"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8016531","DOI":"10.1155\/2020\/8016531","article-title":"Effectiveness and Safety of Oral Chinese Patent Medicines Combined with Chemotherapy for Gastric Cancer: A Bayesian Network Meta-Analysis. Evidence-based complementary and alternative medicine","volume":"2020","author":"Lu","year":"2020","journal-title":"eCAM"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.19746\/J.CNKI.ISSN.1009-2137.2022.01.19","article-title":"Clinical effect of bazhen decoction combined with sequential treatment of chemotherapy on acute lymphoblastic leukemia patients with deficiency of qi and yin","volume":"30","author":"Niu","year":"2022","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"B28","first-page":"9","article-title":"The effect of modified Bazhen decoction combined with chemotherapy on the nutritional status and immune function of postoperative colon cancer patients","volume":"42","author":"Zhang","year":"2023","journal-title":"J Anhui Univ Traditional Chin Med"},{"key":"B29","article-title":"The therapeutic effect of modified Bazhen Tang combined with chemotherapy on postoperative patients with gastric cancer","volume":"23","author":"Jiao","year":"2019","journal-title":"J Pract Clin Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.19347\/j.cnki.2096-1413.202119040","article-title":"Clinical efficacy of Bazhen Tang as an adjuvant chemotherapy in the treatment of advanced non-small cell lung cancer in the elderly","volume":"6","author":"Xu","year":"2021","journal-title":"Clin Med Res Pract"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.13913\/j.cnki.41-1110\/r.2021.02.016","article-title":"Bazhen Decoction combined with neoadjuvant chemotherapy in the treatment of 70 cases of breast cancer","volume":"36","author":"Chen","year":"2021","journal-title":"Natl Med Forum"},{"key":"B32","article-title":"Modified Bazhen Tang combined with radiotherapy for the treatment of advanced cervical cancer and its effect on the cellular immune level and nutritional status of patients","volume":"43","author":"Wu","year":"2022","journal-title":"Shaanxi Traditional Chin Med"},{"key":"B33","article-title":"Clinical observation of modified Bazhen Tang combined with capecitabine in the maintenance treatment of elderly patients with advanced colon cancer","volume":"29","author":"Xu","year":"2022","journal-title":"Chin J Traditional Chin Med Sci Technol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.13935\/j.cnki.sjzx.200833","article-title":"Observation on the efficacy of Bazhen Tang combined with chemotherapy in the treatment of advanced colon cancer","volume":"15","author":"Zhou","year":"2020","journal-title":"World J Integrated Traditional Chin Western Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2023.1155677","article-title":"Exploring the potential targets of the Abrus cantoniensis Hance in the treatment of hepatitis E based on network pharmacology","volume":"10","author":"Xu","year":"2023","journal-title":"Front Vet Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0:a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2016.04.01","article-title":"A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma","volume":"7","author":"Mok","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1076","article-title":"Therapeutic target databaseupdate 2018: enriched resource for facilitating bench-to-clinicresearch of targeted therapeutics","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"bav028","DOI":"10.1093\/database\/bav028","article-title":"DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes","volume":"2015","author":"Pi\u00f1ero","year":"2015","journal-title":"Database"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv557","article-title":"Cytoscape.js: a graph theory library for visualisation and analysis","volume":"32","author":"Franz","year":"2016","journal-title":"Bioinformatics"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.665080","article-title":"Bioinformatics, molecular docking and experiments in vitro analyze the prognostic value of CXC chemokines in breast cancer","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"116333","DOI":"10.1016\/j.jep.2023.116333","article-title":"Qingdai Decoction suppresses prostate cancer growth in lethal-stage prostate cancer models","volume":"308","author":"Chen","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.848355","article-title":"Shuxie-1 decoction alleviated CUMS -induced liver injury via IL-6\/JAK2\/STAT3 signaling","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4180","article-title":"Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme","volume":"36","author":"Triplett","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32715","article-title":"Blockade of T-cell receptor with Ig and ITIM domains elicits potent antitumor immunity in naturally occurring HBV-related HCC in mice","volume":"77","author":"Wu","year":"2023","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.7150\/thno.47137","article-title":"USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer","volume":"10","author":"Dai","year":"2020","journal-title":"Theranostics"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005619","article-title":"Enhanced efficacy of direct immunochemotherapy for hepatic cancer with image-guided intratumoral radiofrequency hyperthermia","volume":"10","author":"Kan","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.416","article-title":"PD-1(+) CD8(+) T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients","volume":"111","author":"Wu","year":"2014","journal-title":"Br J Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"B50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability- adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"8","author":"Kocarnik","year":"2021","journal-title":"JAMA Oncol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3322\/caac.21728","article-title":"Clinical management of metastatic colorectal cancer in the era of precision medicine","volume":"72","author":"Ciardiello","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1105180","article-title":"Radioimmunotherapy in colorectal cancer treatment: present and future","volume":"14","author":"Shi","year":"2023","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1132141","article-title":"Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer","volume":"13","author":"Lin","year":"2023","journal-title":"Front Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13020-023-00719-7","article-title":"Traditional Chinese medicine for colorectal cancer treatment: potential targets and mechanisms of action","volume":"18","author":"Chen","year":"2023","journal-title":"Chin Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/s0254-6272(16)30034-6","article-title":"Therapeutic targets of Traditional Chinese Medicine for colorectal cancer","volume":"36","author":"Li","year":"2016","journal-title":"J Tradit Chin Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13099-019-0299-4","article-title":"Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer","volume":"11","author":"Fei","year":"2019","journal-title":"Gut Pathog"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3875-5","article-title":"Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trial","volume":"26","author":"Zimmer","year":"2018","journal-title":"Support Care Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"110667","DOI":"10.1016\/j.cellsig.2023.110667","article-title":"Quercetin modulates signal transductions and targets non-coding RNAs against cancer development","volume":"107","author":"Homayoonfal","year":"2023","journal-title":"Cell Signal"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12896","article-title":"A comprehensive view on the quercetin impact on bladder cancer: Focusing on oxidative stress, cellular, and molecular mechanisms","volume":"37","author":"Golmohammadi","year":"2023","journal-title":"Fundam Clin Pharmacol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1077531","article-title":"The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update","volume":"14","author":"Lotfi","year":"2023","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/pharmaceutics15020712","article-title":"Apoptotic mechanisms of quercetin in liver cancer: recent trends and advancements","volume":"15","author":"Sethi","year":"2023","journal-title":"Pharmaceutics"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.3390\/ijms24032952","article-title":"Targets involved in the anti-cancer activity of quercetin in breast, colorectal and liver neoplasms","volume":"24","author":"Maugeri","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.9b02875","article-title":"Nanoformulated codelivery of quercetin and alantolactone promotes an antitumor response through synergistic immunogenic cell death for microsatellite-stable colorectal cancer","volume":"13","author":"Zhang","year":"2019","journal-title":"ACS Nano"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7297","article-title":"Quercetin inhibiting the PD-1\/PD-L1 interaction for immune-enhancing cancer chemopreventive agent","volume":"35","author":"Jing","year":"2021","journal-title":"Phytother Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.3390\/molecules24122277","article-title":"Kaempferol: a key emphasis to its anticancer potential","volume":"24","author":"Imran","year":"2019","journal-title":"Molecules"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.8b02656","article-title":"Reactive Oxygen Species and p53 Mediated Activation of p38 and Caspases is Critically Involved in Kaempferol Induced Apoptosis in Colorectal Cancer Cells","volume":"66","author":"Choi","year":"2018","journal-title":"J Agric Food Chem"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.974896","article-title":"Regulation of dietary polyphenols on cancer cell pyroptosis and the tumor immune microenvironment","volume":"9","author":"Huang","year":"2022","journal-title":"Front Nutr"},{"key":"B69","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/antiox9020180","article-title":"Pharmacological targets of kaempferol within inflammatory pathways-A hint towards the central role of tryptophan metabolism","volume":"9","author":"Hofer","year":"2020","journal-title":"Antioxid (Basel)."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2019.08.012","article-title":"Amelioration effects of Kaempferol on immune response following chronic intermittent cold-stress","volume":"125","author":"Jia","year":"2019","journal-title":"Res Vet Sci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"498","DOI":"10.5114\/ada.2020.94257","article-title":"Inhibitory effect of kaempferol on mouse melanoma cell line B16 in vivo and in vitro","volume":"38","author":"Qiang","year":"2021","journal-title":"Adv Dermatol Allergol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.3390\/ijms23073544","article-title":"Kaempferol can reverse the 5-fu resistance of colorectal cancer cells by inhibiting PKM2-mediated glycolysis","volume":"23","author":"Wu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"5875074","DOI":"10.1155\/2020\/5875074","article-title":"Licochalcone a induces ROS-mediated apoptosis through trxR1 inactivation in colorectal cancer cells","volume":"2020","author":"Wu","year":"2020","journal-title":"BioMed Res Int"},{"key":"B74","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1742-7843.2008.00238.x","article-title":"Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice","volume":"103","author":"Lee","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"153394","DOI":"10.1016\/j.phymed.2020.153394","article-title":"Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells","volume":"80","author":"Y uan","year":"2021","journal-title":"Phytomedicine"},{"key":"B76","doi-asserted-by":"publisher","first-page":"113989","DOI":"10.1016\/j.jep.2021.113989","article-title":"Licochalcone A inhibits proliferation and promotes apoptosis of colon cancer cell by targeting programmed cell death-ligand 1 via the NF-\u03baB and Ras\/Raf\/MEK pathways","volume":"273","author":"Liu","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202704","article-title":"Licochalcone A improves the cognitive ability of mice by regulating T- and B-cell proliferation","volume":"13","author":"Wu","year":"2021","journal-title":"Aging (Albany NY)."},{"key":"B78","doi-asserted-by":"publisher","first-page":"120752","DOI":"10.1016\/j.lfs.2022.120752","article-title":"Naringenin: A potential flavonoid phytochemical for cancer therapy","volume":"305","author":"Motallebi","year":"2022","journal-title":"Life Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03149-w","article-title":"Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration","volume":"71","author":"Kawaguchi","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900278","article-title":"Naringenin enhances the antitumor effect of therapeutic V accines by promoting antigen cross-presentation","volume":"204","author":"Wang","year":"2020","journal-title":"J Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-011-1056-8","article-title":"Naringenin reduces lung metastasis in a breast cancer resection model","volume":"2","author":"Qin","year":"2011","journal-title":"Protein Cell"},{"key":"B82","doi-asserted-by":"publisher","first-page":"110301","DOI":"10.1016\/j.biopha.2020.110301","article-title":"Isorhamnetin: A review of pharmacological effects","volume":"128","author":"Gong","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3736\/jintegrmed2013057","article-title":"Diarylheptanoid-myricanone isolated from ethanolic extract of Myrica cerifera shows anticancer effects on HeLa and PC3 cell lines: signalling pathway and drug-DNA interaction","volume":"11","author":"Paul","year":"2013","journal-title":"J Integr Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1159\/000371738","article-title":"In vitro anticancer activity of myricanone in human lung adenocarcinoma A549 cells","volume":"60","author":"Dai","year":"2014","journal-title":"Chemotherapy"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jams.2013.05.003","article-title":"Anticancer potential of myricanone, a major bioactive component of Myrica cerifera: novel signaling cascade for accomplishing apoptosis","volume":"6","author":"Paul","year":"2013","journal-title":"J Acupunct Meridian Stud"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.5348","article-title":"A review: the pharmacology of isoliquiritigenin","volume":"29","author":"Peng","year":"2015","journal-title":"Phytother Res Ptr"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2020.1825092","article-title":"The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK\/mTOR mediated glycolysis in colorectal cancer","volume":"48","author":"Wang","year":"2020","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/cancers13010115","article-title":"Perspectives on the role of isoliquiritigenin in cancer","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00820","article-title":"Formononetin: A review of its anticancer potentials and mechanisms","volume":"10","author":"Tay","year":"2019","journal-title":"Front Pharmacol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"108899","DOI":"10.1016\/j.jnutbio.2021.108899","article-title":"Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation","volume":"100","author":"Wang","year":"2022","journal-title":"J Nutr Biochem"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3969","article-title":"Resveratrol suppresses colon cancer growth by targeting the AKT\/STAT3 signaling pathway","volume":"43","author":"Li","year":"2018","journal-title":"Int J Mol Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1158\/2326-6066.CIR-14-0095","article-title":"Selective inhibition of regulatory T cells by targeting the PI3KAkt pathway","volume":"2","author":"Abu-Eid","year":"2014","journal-title":"CancerImmunol Res"},{"key":"B93","doi-asserted-by":"publisher","first-page":"104623","DOI":"10.1016\/j.phrs.2019.104623","article-title":"Modified Bu-zhong-yi-qi decoction synergies with 5 fluorouracile to inhibits gastric cancer progress via PD-1\/PD- L1-dependent T cell immunization","volume":"152","author":"Xu","year":"2020","journal-title":"Pharmacol Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.cels.2018.03.003","article-title":"Pan- cancer alterations of the MYC oncogene and its proximal network across The Cancer Genome Atlas","volume":"6","author":"Schaub","year":"2018","journal-title":"Cell Syst"},{"key":"B95","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/genes8060151","article-title":"MYC deregulation in primary human cancers","volume":"8","author":"Kalkat","year":"2017","journal-title":"Genes"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-018-0650-z","article-title":"The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis","volume":"12","author":"Carroll","year":"2018","journal-title":"Front Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-742577","article-title":"The MYC oncogene is a global regulator of the immune response","volume":"131","author":"Casey","year":"2018","journal-title":"Blood"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2018.03.09","article-title":"Myc and Ras, the Bonnie and Clyde of immune evasion","volume":"7","author":"Casacuberta- Serra","year":"2018","journal-title":"Transl Cancer Res"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-022-00898-7","article-title":"Myc inhibition tips the immune balance to promote antitumor immunity","volume":"19","author":"Yang","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31374","article-title":"Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells","volume":"143","author":"Zhou","year":"2018","journal-title":"Int J Cancer"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32345","article-title":"ESR1 mutations in breast cancer","volume":"125","author":"Dustin","year":"2019","journal-title":"Cancer"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.7","article-title":"SPSB1-mediated HnRNP A1 ubiquitylation regulates alternative splicing and cell migration in EGF signaling","volume":"27","author":"Wang","year":"2017","journal-title":"Cell Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-016-9649-6","article-title":"The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer","volume":"35","author":"Hsu","year":"2016","journal-title":"Cancer Metastasis Rev"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.84","article-title":"Understanding and targeting resistance mechanisms in NSCLC","volume":"17","author":"Rotow","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2013.11.002","article-title":"The ErbB\/HER family of protein-tyrosine kinases and cancer","volume":"79","author":"Roskoski","year":"2014","journal-title":"Pharm Res"},{"key":"B106","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.3390\/ijms23126489","article-title":"EGFR-mutated non-small cell lung cancer and resistance to immunotherapy: role of the tumor microenvironment","volume":"23","author":"Madeddu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B107","doi-asserted-by":"publisher","first-page":"145796","DOI":"10.1016\/j.gene.2021.145796","article-title":"Up-down regulation of HIF-1\u03b1 in cancer progression","volume":"798","author":"Rashid","year":"2021","journal-title":"Gene"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2598","article-title":"Mechanisms of hypoxia-mediated immune escape in cancer","volume":"74","author":"Barsoum","year":"2014","journal-title":"Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-019-1299-4","article-title":"Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis","volume":"36","author":"Giatromanolaki","year":"2019","journal-title":"Med Oncol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150846","article-title":"Targeting HIF-1\u03b1 abrogates PD-L1-mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues","volume":"132","author":"Bailey","year":"2022","journal-title":"J Clin Invest"},{"key":"B111","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/biom11010128","article-title":"Exploring the intracrine functions of VEGF-A","volume":"11","author":"Wiszniak","year":"2021","journal-title":"Biomolecules"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.2174\/1570161115666170105124038","article-title":"Vascular endothelial growth factor (VEGF) signaling in tumour vascularization: potential and challenges","volume":"15","author":"Siveen","year":"2017","journal-title":"Curr Vasc Pharmacol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/bs.ircmb.2016.09.007","article-title":"Immunomodulatory activity of VEGF in cancer","volume":"330","author":"Lapeyre-Prost","year":"2017","journal-title":"Int Rev Cell Mol Biol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140559","article-title":"VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors","volume":"212","author":"Voron","year":"2015","journal-title":"J Exp Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4709","article-title":"The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies","volume":"69","author":"Ozao-Choy","year":"2009","journal-title":"Cancer Res"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-011-1113-3","article-title":"c-Jun, at the crossroad of the signaling network","volume":"2","author":"Meng","year":"2011","journal-title":"Protein Cell"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302158","article-title":"Dominant-negative mutant of c-Jun gene transfer: A novel therapeutic strategy for colorectal cancer","volume":"11","author":"Suto","year":"2004","journal-title":"Gene Ther"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-13-0117","article-title":"a natural inhibitor of c-Jun N-terminal kinase 1","volume":"7","author":"Yao","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317424","article-title":"Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion","volume":"69","author":"Jiang","year":"2020","journal-title":"Gut"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3390\/cancers11091280","article-title":"STAT3, a master regulator of anti-tumor immune response","volume":"11","author":"Rebe","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B121","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41568-018-0090-8","article-title":"Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map","volume":"19","author":"Huynh","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B122","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Crosstalk between cancer and immune cells:role of STAT3 in the tumour microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol Cancer"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1039\/C5MB00101C","article-title":"The PI3K\/AKT\/mTOR interactive pathway","volume":"11","author":"Ersahin","year":"2015","journal-title":"Mol Biosyst"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12571","article-title":"PD-1\/PD-L1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumours via the PI3K\/Akt\/mTOR signalling pathway","volume":"52","author":"Zhao","year":"2019","journal-title":"Cell Proliferation"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31357","article-title":"IFN-\u03b3-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling","volume":"143","author":"Gao","year":"2018","journal-title":"Int J Cancer"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/nature20554","article-title":"Overcoming resistance to checkpoint blockade therapy by targeting PI3Kgamma in myeloid cells","volume":"539","author":"De Henau","year":"2016","journal-title":"Nature"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s10059-013-0073-2","article-title":"Orai1-NFAT signalling pathway triggered by T cell receptor stimulation","volume":"35","author":"Srikanth","year":"2013","journal-title":"Mol Cells"},{"key":"B129","doi-asserted-by":"publisher","first-page":"107720","DOI":"10.1016\/j.pharmthera.2020.107720","article-title":"Current developments of targeting the p53 signaling pathway for cancer treatment","volume":"220","author":"Huang","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B130","doi-asserted-by":"publisher","first-page":"8387","DOI":"10.3390\/ijms21218387","article-title":"The Regulation of Ferroptosis by Tumor Suppressor p53 and its Pathway","volume":"21","author":"Liu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.7730","article-title":"Capsaicin mediates cell cycle arrest and apoptosis in human colon cancer cells via stabilizing and activating p53","volume":"10","author":"Jin","year":"2014","journal-title":"Int J Biol Sci"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3969","article-title":"Resveratrol suppresses colon cancer growth by targeting the AKT\/STAT3 signaling pathway","volume":"43","author":"Li","year":"2019","journal-title":"Int J Mol Med"},{"key":"B133","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbrc.2022.01.032","article-title":"Hinokiflavone, as a MDM2 inhibitor, activates p53 signaling pathway to induce apoptosis in human colon cancer HCT116 cells","volume":"594","author":"Zhang","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1021\/jf101510z","article-title":"Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway","volume":"58","author":"Kim","year":"2010","journal-title":"J Agric Food Chem"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13009","article-title":"Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0360","article-title":"Anti-VEGF treatment enhances CD8+ T-cell antitumor activity by amplifying hypoxia","volume":"8","author":"de Almeida","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B137","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/0008-5472.CAN-20-2426","article-title":"Inhibition of FGFR reactivates IFN\u03b3 Signaling in tumor cells to enhance the combined antitumor activity of lenvatinib with anti-PD-1 antibodies","volume":"82","author":"Adachi","year":"2022","journal-title":"Cancer Res"},{"key":"B138","doi-asserted-by":"publisher","first-page":"154672","DOI":"10.1016\/j.phymed.2023.154672","article-title":"Liujunzi decoction exerts potent antitumor activity in oesophageal squamous cell carcinoma by inhibiting miR-34a\/STAT3\/IL-6R feedback loop, and modifies antitumor immunity","volume":"111","author":"Han","year":"2023","journal-title":"Phytomedicine"},{"key":"B139","doi-asserted-by":"publisher","first-page":"111107","DOI":"10.1016\/j.biopha.2020.111107","article-title":"Traditional Chinese medicine compound, Bu Sheng Hui Yang Fang, promotes the proliferation of lymphocytes in the immunosuppressed mice potentially by upregulating IL-4 signaling","volume":"134","author":"Wang","year":"2021","journal-title":"BioMed Pharmacother"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1235575\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T01:58:33Z","timestamp":1695952713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1235575\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":139,"alternative-id":["10.3389\/fimmu.2023.1235575"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1235575","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,20]]},"article-number":"1235575"}}